학술논문

Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
Document Type
Article
Source
In The Lancet Infectious Diseases January 2024 24(1):36-45
Subject
Primary Research
Articles
Language
ISSN
1473-3099